| MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids. | |
| | |
MedLine Citation:
|
PMID: 16918404 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent efforts combining nanotechnology and magnetic properties resulted in the development and commercialization of magnetic nanoparticles that can be used as carriers for nucleic acids for in vitro transfection and for gene therapy approaches including DNA-based vaccination strategies. The efficiency of intracellular delivery is still a limiting factor for basic cell biological research and also for emerging technologies such as temporary gene silencing based on inhibitory RNA/siRNA. Nanotechnology has resulted in a variety of different nanostructures and especially nanoparticles as carriers in a wide range of new drug delivery systems for conventional drugs, recombinant proteins, vaccines and more recently nucleic acids. It is possible to combine superparamagnetic nanoparticles with magnetic forces to increase, direct and optimize intracellular delivery of biomolecules. This article discusses the main approaches in the field of magnet assisted transfection (MATra) focusing on the transfection or intracellular delivery of nucleic acids, although also suitable to improve the intracellular delivery of other biomolecules. |
| | |
Authors:
|
J Bertram |
Related Documents
:
|
19886694 - Efficient nucleic acid detection by templated reductive quencher release. 18655814 - New strategies for nucleic acid delivery to conquer cellular and nuclear membranes. 20603664 - Responsive polyelectrolyte complexes for triggered release of nucleic acid therapeutics. 15016354 - Anion binding to nucleic acids. 22022004 - Effect of folic acid supplementation on oxidative gastric mucosa damage and acid secret... 8479814 - Biologic effects of parenteral bisulfite on human vascular tissue. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current pharmaceutical biotechnology Volume: 7 ISSN: 1389-2010 ISO Abbreviation: Curr Pharm Biotechnol Publication Date: 2006 Aug |
Date Detail:
|
Created Date: 2006-08-21 Completed Date: 2006-10-02 Revised Date: 2008-05-12 |
Medline Journal Info:
|
Nlm Unique ID: 100960530 Medline TA: Curr Pharm Biotechnol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 277-85 Citation Subset: IM |
Affiliation:
|
IBA BioTAGnology GmbH, Rudolf-Wissell-Str. 28, 37079 Göttingen, Germany. bertram@iba-go.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Delivery Systems Humans Magnetics* Nanotechnology / methods* Nucleic Acids / administration & dosage* RNA, Small Interfering / administration & dosage Transfection / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Nucleic Acids; 0/RNA, Small Interfering |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel delivery technologies for protein and peptide therapeutics.
Next Document: Accounting for triplet and saturation effects in FCS measurements.